ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PRPH ProPhase Labs Inc

4.575
-0.035 (-0.76%)
Last Updated: 13:11:11
Delayed by 15 minutes

Period:

Draw Mode:

Volume 45,162
Bid Price 4.55
Ask Price 4.63
News -
Day High 4.725

Low
4.05

52 Week Range

High
9.9412

Day Low 4.45
Share Name Share Symbol Market Stock Type
ProPhase Labs Inc PRPH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.035 -0.76% 4.575 13:11:11
Open Price Low Price High Price Close Price Previous Close
4.59 4.45 4.725 4.61
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
188 45,162 US$ 4.59 US$ 207,493 - 4.05 - 9.9412
Last Trade Type Quantity Price Currency
13:00:05 100 US$ 4.575 USD

ProPhase Labs Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
82.47M 18.05M - 44.38M -16.78M -0.93 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ProPhase Labs News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PRPH Message Board. Create One! See More Posts on PRPH Message Board See More Message Board Posts

Historical PRPH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.895.464.454.8225,270-0.315-6.44%
1 Month6.957.484.455.78106,513-2.38-34.17%
3 Months5.007.484.37345.6054,282-0.425-8.50%
6 Months4.497.484.255.2939,2280.0851.89%
1 Year7.689.94124.056.3648,284-3.11-40.43%
3 Years5.2515.254.057.8489,387-0.675-12.86%
5 Years3.0116.041.377.2794,2271.5751.99%

ProPhase Labs Description

ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

Your Recent History

Delayed Upgrade Clock